Clinical Study Results

• PEG 400 - Healthy

  Clinical Study Number	352.2030
  Study Indication	Healthy
  Product	PEG 400
  Generic Name	PEG 400
  Lab Code
  Clinical Phase	I
  Study Title	Safety of total daily doses of 5, 10, 15 and 20 mL PEG 400 administered orally to healthy male human subjects once (QD) or twice (BID) for 14 days. A single center, multiple rising dose study, placebo controlled, double-blinded at each dose level.
  Study Document	Trial synopsis 352.2030_CO english